R, S., R, O., G, F., C, P., M, D., D, T., . . . Investigators, F. I. a. E. L. i. D. S. (2009). Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetes Care, 32(3), 493. https://doi.org/10.2337/dc08-1543
Chicago Style (17th ed.) CitationR, Scott, et al. "Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals with Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study." Diabetes Care 32, no. 3 (2009): 493. https://doi.org/10.2337/dc08-1543.
MLA (9th ed.) CitationR, Scott, et al. "Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals with Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study." Diabetes Care, vol. 32, no. 3, 2009, p. 493, https://doi.org/10.2337/dc08-1543.
